Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director

SAN DIEGO, June 23, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc. ® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced its Board of Directors has appointed a new independent director,

Related Keywords

Carol Gallagher ,Eli Lilly ,Calistoga Pharmaceuticals ,University Of Kentucky ,Prnewswire Mirati Therapeutics Inc ,Nasdaq ,Enterprise Associates ,Exchange Commission ,Mirati Therapeutics Inc ,Agouron Pharmaceuticals ,Bristol Myers Squibb ,Amgen ,Gilead Sciences ,Anadys Pharmaceuticals ,Board Of Trustees For The Salk Institute ,Pfizer ,Vanderbilt University ,David Meek ,Mirati Therapeutics ,New Enterprise Associates ,Idec Pharmaceutics ,Turning Point ,Emirati Board ,